Technology
Health
Biotechnology

CytomX

$7.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+1.14%) Today
+$0.01 (+0.14%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CytomX and other stocks, options, ETFs, and crypto commission-free!

About CTMX

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. Read More The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CEO
Sean A. McCarthy
Employees
158
Headquarters
South San Francisco, California
Founded
2010
Market Cap
326.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
468.91K
High Today
$7.33
Low Today
$6.96
Open Price
$7.10
Volume
461.83K
52 Week High
$15.44
52 Week Low
$3.60

Collections

Technology
Health
Biotechnology
Therapy
Cancer Prevention
2015 IPO
US
North America

CTMX News

ReutersAug 7

Edited Transcript of CTMX earnings conference call or presentation 6-Aug-20 9:30pm GMT

Q2 2020 CytomX Therapeutics Inc Earnings Call SOUTH SAN FRANCISCO Aug 8, 2020 (Thomson StreetEvents) -- Edited Transcript of CytomX Therapeutics Inc earnings c

CTMX Earnings

-$0.79
-$0.44
-$0.09
$0.26
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
$0.16 per share
Actual
-$0.34 per share
Replay Earnings Call

You May Also Like

ORCC
VTR
NEED
ERYP
LSTR
LXU
PSC
FWRD
LAND
CLXT
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CTMX

Market Price$7.08
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CytomX stock and options commission-free.
LearnBlogCareersHelpLog InSign Up